Sanofi has announced that it will lower the list price of its insulin drug, Lantus, by 78 percent and will set a $35 cap on out-of-pocket costs for all patients.
The price change and cap will go into effect starting January 1, 2024. They follow a series of moves made last year to lower the price of diabetes medicine, including the launch of an unbranded version of Lantus and a $35 cap for uninsured patients.
Yet, Olivier Bogillot, head of U.S. general medicines at Sanofi, said "the health system was unable to take advantage of it due to its inherent structural challenges."
“Sanofi believes that no one should struggle to pay for their insulin and we are proud of our continued actions to improve access and affordability for millions of patients for many years," he said. "Our decision to cut the list price of our lead insulin needs to be coupled with broader change to the overall system to actually drive savings for patients at the pharmacy counter.”
Sanofi will also cut the price of short-acting Apidra by 70 percent.
Stretching Your Dollar: What to Know About Income-Based Repayment Student Loans
Trucking company Yellow Corp. has declared bankruptcy after years of financial struggles and growing debt, marking a significant shift for the U.S. transportation industry and shippers nationwide.
Stretching Your Dollar: Summer Savings on Car Rentals
Stretching Your Dollar: What to Know About Junk Fees
Stretching Your Dollar: Benefits of Outlet Shopping
Elon Musk said his cage fight against Mark Zuckerberg will stream on 'X,' the app formerly known as Twitter.
Oregon drivers can now pump their own gas for the first time since 1951.
A woman is suing Southwest Airlines for racial discrimination after an employee reportedly called police to report her on suspicion of child trafficking.
Stocks jumped early Monday as the market rebounds from a losing week with earnings coming in better than expected and investors await new inflation data.
The Dungeons & Dragons role-playing game franchise says it won't allow artists to use artificial intelligence technology to draw its cast of sorcerers, druids and other characters and scenery.
